Critical Diagnostics Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
Critical Diagnostics General Information
Description
Developer of a cardiac biomarker designed to treat cardiovascular diseases. The company's biomarkers provide in vitro diagnostic tests that quantitatively measure ST2 in serum or plasma by enzyme-linked immunosorbent assay (ELISA) in a microtiter plate format, enabling medical professionals to aid heart patients and to lead healthier lives while reducing healthcare costs.
Contact Information
Website
www.criticaldiagnostics.comCorporate Office
- 3030 Bunker Hill Street
- Suite 117A
- San Diego, CA 92109
- United States
Corporate Office
- 3030 Bunker Hill Street
- Suite 117A
- San Diego, CA 92109
- United States
Critical Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Oct-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 03-Jan-2018 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 26-Mar-2013 | $2.57M | $2.57M | Completed | Generating Revenue | |
| 1. Seed Round | 18-Oct-2004 | Completed | Startup |
Critical Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Critical Diagnostics Comparisons
Industry
Financing
Details
Critical Diagnostics Competitors (3)
One of Critical Diagnostics’s 3 competitors is Kardium, a Private Equity-Backed company based in Burnaby, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kardium | Private Equity-Backed | Burnaby, Canada | ||||
| NeuroSigma | Venture Capital-Backed | Los Angeles, CA | ||||
| CardioFocus | Venture Capital-Backed | Marlborough, MA |
Critical Diagnostics Patents
Critical Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2773471-T3 | St2 cardiac biomarker assay apparatus | Active | 11-Dec-2014 | ||
| AU-2015360396-A1 | Test apparatus and methods for st2 cardiac biomarker | Inactive | 11-Dec-2014 | ||
| CA-2970316-A1 | Test apparatus and methods for st2 cardiac biomarker | Inactive | 11-Dec-2014 | ||
| EP-3230738-A2 | Test apparatus and methods for st2 cardiac biomarker | Active | 11-Dec-2014 | ||
| EP-3230738-A4 | Test apparatus and methods for st2 cardiac biomarker | Active | 11-Dec-2014 | G01N33/6893 |
Critical Diagnostics Signals
Critical Diagnostics FAQs
-
When was Critical Diagnostics founded?
Critical Diagnostics was founded in 2004.
-
Where is Critical Diagnostics headquartered?
Critical Diagnostics is headquartered in San Diego, CA.
-
What is the size of Critical Diagnostics?
Critical Diagnostics has 6 total employees.
-
What industry is Critical Diagnostics in?
Critical Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Critical Diagnostics a private or public company?
Critical Diagnostics is a Private company.
-
What is Critical Diagnostics’s current revenue?
The current revenue for Critical Diagnostics is .
-
How much funding has Critical Diagnostics raised over time?
Critical Diagnostics has raised $11.1M.
-
Who are Critical Diagnostics’s competitors?
Kardium, NeuroSigma, and CardioFocus are competitors of Critical Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process